1. A. A registrant shall ensure the use of a radiofrequency source regulated under this Article for diagnostic or therapeutic purposes complies with the requirements in R9-7-1404(B)(2) and (3) and (E).
2. B. A registrant shall ensure that the use of a sunlamp product regulated under this Article for diagnostic or therapeutic purposes complies with applicable requirements in R9-7-1405.

3. C. A registrant shall ensure that:

   1. 1. The use of an intense pulsed light device regulated under this Article for diagnostic or therapeutic purposes complies with applicable requirements and manufacturer’s specifications, and
   2. 2. The manufacturer’s user manual for the intense pulsed light device is available on-site.

4. D. In addition to the requirements in R9-7-1407, a registrant shall ensure that a Class 3b or Class 4 laser product used for diagnostic or therapeutic purposes:

   1. 1. Is appropriate for the diagnostic or therapeutic purpose for which the laser product is used;
   2. 2. Has a means for measuring the level of laser radiation with an error in measurement of no greater than +20%, when calibrated in accordance with the laser product manufacturer’s calibration procedure;
   3. 3. Is calibrated according to the manufacturer’s specified calibration procedure, at intervals that do not exceed those specified by the manufacturer; and
   4. 4. Has a guard mechanism on the switch to control patient exposure and prevent inadvertent exposure.

5. E. A registrant shall:

   1. 1. Ensure that policies and procedures are established, documented, and implemented to protect the health and safety of a patient that comply with requirements in R9-7-1409(6) and R9-7-1413;
   2. 2. Comply with R9-7-1408(D) and R9-7-1411;

   3. 3. In a facility where a Class 3b or Class 4 laser product is used for diagnostic or therapeutic purposes, ensure that a laser safety training program is established, documented, and maintained that:

      1. a. Provides for a thorough understanding of established procedures for the use of each type of laser product and the diagnostic or therapeutic procedures associated with the use of the laser; and
      2. b. Is consistent with R9-7-1408(C)(3) or R9-7-1413, as applicable to the user; and
   4. 4. Make documentation of the laser safety training program in subsection (E)(3) available to the Department upon request.

6. F. In a facility where two or more medical disciplines or a number of different health professionals use Class 3b and Class 4 laser products for diagnostic or therapeutic purposes, a registrant shall:

   1. 1. Form a laser safety committee to govern laser activity, establish use criteria, and approve operating procedures;
   2. 2. Ensure that the laser safety committee is comprised of at least one registered nurse as defined in A.R.S. § 32-1601, the Laser Safety Officer, one management representative, and one representative of each medical discipline that uses a laser;
   3. 3. Ensure that the laser safety committee meets at least once each calendar year;
   4. 4. Ensure that the laser safety committee reviews actions by the Laser Safety Officer related to hazard evaluation and the monitoring and control of laser hazards, consistent with requirements in R9-7-1409 and the policies and procedures in subsection (E)(1);
   5. 5. Ensure that the laser safety committee approves policies and procedures, consistent with R9-7-1408(C)(3) or R9-7-1413, as applicable, and the laser safety training program in subsection (E)(3), that describe the appropriate training and competency of an individual who may be approved to operate or assist in the operation of a laser; and

   6. 6. Ensure that the laser safety committee approves or denies requests to operate or assist in the operation of a laser, based on the policies and procedures in subsection (F)(5), by:

      1. a. A health professional, or
      2. b. A potential operator of a laser product under the direction and supervision of a prescribing health professional.

Historical Note

New Section R9-7-1412 recodified from R12-1-1412 at 24 A.A.R. 813, effective March 22, 2018 (Supp. 18-1).

Section R9-7-1412 repealed; new Section R9-7-1412 renumbered from R9-7-1440 and amended by final expedited rulemaking at 32 A.A.R. 721 (March 27, 2026, Issue 13) with an immediate effective date of March 5, 2026 (Supp. 26-1).